Accelerated hypofractionated chemoradiation followed by stereotactic ablative radiotherapy boost for locally advanced, unresectable non-small cell lung cancer

被引：0
|
作者：
Weber, Urs M. [1 ]
Watson, Alexander S. [1 ]
Kavanagh, Brian D. [2 ]
Bunn, Paul A. [1 ]
机构：
[1] Univ Colorado, Sch Med, Dept Med, Div Med Oncol, MS 8117,12801 E 17th Ave, Aurora, CO 80045 USA
[2] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2025年 / 14卷 / 02期
关键词：
Stage III non-small cell lung cancer (stage III NSCLC); stereotactic body radiation therapy boost (SBRT boost); hypofractionated radiation; VOLUME;
D O I：
10.21037/tcr-24-1869
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：676 / 678
页数：3
相关论文
共 50 条
  • [1] Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer A Nonrandomized Controlled Trial
    Wu, Trudy C.
    Luterstein, Elaine
    Neilsen, Beth K.
    Goldman, Jonathan W.
    Garon, Edward B.
    Lee, Jay M.
    Felix, Carol
    Cao, Minsong
    Tenn, Stephen E.
    Low, Daniel A.
    Kupelian, Patrick A.
    Steinberg, Michael L.
    Lee, Percy
    JAMA ONCOLOGY, 2024, 10 (03) : 352 - 359
  • [2] Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: Final Results from a Nonrandomized Controlled Clinical Trial
    Lee, P.
    Goldman, J.
    Garon, E.
    Luterstein, E.
    Neilsen, B. K.
    Lee, J. M.
    Felix, C.
    Cao, M.
    Tenn, S. E.
    Low, D.
    Kupelian, P. A.
    Steinberg, M. L.
    Wu, T. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S107 - S107
  • [3] Feasibility of stereotactic ablative radiotherapy for locally-advanced non-small cell lung cancer
    Woodford, K.
    Panettieri, V.
    Le, T. Tran
    Senthi, S.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S555 - S556
  • [4] Stereotactic radiotherapy for unresectable locally advanced non small cell lung cancer
    Arcidiacono, F.
    Anselmo, P.
    Trippa, F.
    Casale, M.
    Italiani, M.
    Draghini, L.
    Terenzi, S.
    Fabiani, S.
    Di Marzo, A.
    Maranzano, E.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S545 - S545
  • [5] Late-course hypofractionated stereotactic radiotherapy for locally advanced non-small cell lung cancer
    Li, J
    Ma, Z
    Guo, S
    Yin, Y
    Lu, J
    Yu, J
    Tian, S
    Liang, C
    Yu, N
    Zhang, Y
    Shao, Q
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S284 - S285
  • [6] MODERN-LUNG: A phase 2 study of a moderately hypofractionated schedule of chemoradiation followed by immunotherapy for unresectable locally advanced non-small cell lung cancer
    Ludbrook, Joanna Jane
    Vinod, Shalini
    Kumar, Mahesh
    Mallesara, Girish
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 46 - 47
  • [7] Feasibility of Stereotactic Ablative Radiotherapy (SABR) for Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)
    Woodford, Katrina
    Panettieri, Vanessa
    Trieumy Tran Le
    Senthi, Sashendra
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1467 - S1468
  • [8] Stereotactic Body Radiotherapy for Unresectable Locally-Advanced Non Small Cell Lung Cancer
    Arcidiacono, F.
    Casale, M.
    Anselmo, P.
    Trippa, F.
    Draghini, L.
    Terenzi, S.
    Di Marzo, A.
    Italiani, M.
    Fabiani, S.
    Maranzano, E.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S754 - S754
  • [9] Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis
    Viani, Gustavo A.
    Gouveia, Andre G.
    Louie, Alexander, V
    Arcidiacono, Fabio
    Simone II, Charles B.
    Tsakiridis, Theodoros
    Hamamura, Ana Carolina
    Anselmo, Paola
    Moraes, Fabio Y.
    RADIOTHERAPY AND ONCOLOGY, 2024, 201
  • [10] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
12345